Member Info for Dibs61

OK deep breath. In the total absence of newsflow technicals do start to come into play more. A full Fibonacci retrace of 61.8% from our day close peak of 66p gives us a SP of almost exactly 40p. Without any announcements thats where we could be headed. I will be throwing the kitchen sink at it to double my shareholding if it reaches that level but, as I say, without news, prob a bit further to go. For the moment I protect my average.

To give you an idea ODX are selling their Visitect CD4 POC Test in Africa for $3.98 (lets call it $4) with roughly a 65% margin built in. Much more competitive than their inferior competitors I might add. They are projected to be selling millions of those in the next few years (orders already coming in) so even without Covid this is a cash cow in the making. The UK government are right behind this so a route to market will not be a problem with the supply chain sorted and secured.

Do yourselves a favour and just do a LITTLE bit of research lol

playingtheodds - no this is not the case. The company have already confirmed this is a commercial venture - not a not for profit enterprise - don't you think the market would've cottoned on to that before it reached a £100MC?

The drift absolutely does not point to anything untoward. It points to impatient nervous and often unknowledgeable punters, as well as a few cautious ones. Thats all. There were high expectations of the design freeze having dropped by now. I am as guilty as anybody of that but realistically they are attempting to achieve something that often takes months or even years to achieve. The hope is that because they have pooled the finest industry minds in the nation behind it in the Rapid Test Consortium they will pull it off and there is clearly great confidence about that. I've written all this and then noticed you're not bothered anyway so wont continue any further. A missed opportunity IMHO.

Apologies if already previously posted, don't remember seeing it though. Printed a couple of weeks ago but a very good insight into Omega's position in the Covid space, especially those that are new to the companys situation.

https://www.nsmedicaldevices.com/analysis/uk-covid-19-antibody-testing/

We seem to have a support level here for SP. Story has not changed one iota. We are still the front runners and have the all important govt backing and expertise of Oxford Univ boffins behind us.

Is there still hope for Puni?

Just bought 250k @ 1.3p

Been watching for a while.

Looks like most of them are getting a shake this morning

I think creating and designing the kit is probably the easy part because they already have basic template models to reconfigure in whatever way required. The harder part is likely to be to achieve the very high bar of specificity and sensitivity required. Plus the fact they have to wait for the igG antibodies which come later after infection to test its efficacy.

But I think they will crack it.

Have you got any good questions?

Note in particular this paragraph.

"We must read this as a wake-up call to countries to identify ways to sustain all vital health services. For HIV, some countries are already taking important steps, for example ensuring that people can collect bulk packs of treatment, and other essential commodities, including self-testing kits, from drop-off points, which relieves pressure on health services and the health workforce. We must also ensure that global supplies of tests and treatments continue to flow to the countries that need them."

The Guardian says:

Covid-19 disruption could double Aids deaths - WHO
Half a million more people could die from Aids-related illnesses in sub-Saharan Africa if efforts are not made to overcome interruptions to health services as a result of the coronavirus pandemic, the World Health Organization has warned.

According to the modelling carried out on behalf of the WHO and UNAids, the disruption to health services could take Aids-related deaths in the next year in the region back to 2008 levels, when it claimed 950,000 lives.

“And people would continue to die from the disruption in large numbers for at least another five years, with an annual average excess in deaths of 40% over the next half a decade,” the agencies said. “In addition, HIV service disruptions could also have some impact on HIV incidence in the next year.”

Tedros Adhanom Ghebreyesus, the director general of the WHO, was quoted as saying:

The terrible prospect of half a million more people in Africa dying of Aids-related illnesses is like stepping back into history.

We must read this as a wake-up call to countries to identify ways to sustain all vital health services. For HIV, some countries are already taking important steps, for example ensuring that people can collect bulk packs of treatment, and other essential commodities, including self-testing kits, from drop-off points, which relieves pressure on health services and the health workforce. We must also ensure that global supplies of tests and treatments continue to flow to the countries that need them.

In sub-Saharan Africa, an estimated 25.7 million people were living with HIV and 16.4 million (64%) were taking antiretroviral therapy in 2018.

The message is clear. There needs to be a renewed focus on HIV treatment - which is HIGHLY relevant to ODX in the next two years.

Def all sells going on spread at that minute

As Torre says clearing a few more out

Plenty of scope here me thinks. ;)

fjones - so now you're trying to claim you sold @ 66/67?? Massive porky there sir......... I seem to recall it was in the mid to upper fifties no? It's easy to track back and see but I have better things to do with my time.

Cheers flyingmachine it got lost somewhere!

A very well done indeed and particularly those that got in around 0.5-0.7 blinding work. Credit where credits due!

Elon largely agree with your thoughts. Daily disappointment at no RNS, doubts creep in, traders move on then come back for next days possible RNS. We’ve not had any official update since 9th April but it’s politically sensitive so not a normal market development where the company can communicate more easily.

The Mologic Rapid POC Test, I’m trying to dig out the S&S level but seem to recall it was less than that required by PHE and no regulatory approval for UK market yet.

Mars1 - sorry have to correct you there, Nigeria did not go for ODX’s HIV test because ODX do not have an HIV test. ODX have a rapid POC test which tests for the level of CD4 cells in your blood. This gives a strong indication of disease level as it measures your immune system through the T cells.

Good morning All, am I on the wrong BB is this AVCT or ODX? Shame we don't have a moderator to eliminate all this spam.